Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins

International Journal of Cancer

Volumn 103, Issue 1, 2003, Pages 38-44

  Young, M Rita I ^a,b   Liu, Shirley W ^a   Meisinger, Jeremy ^b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Focal adhesions; Metastasis; Migration; Paxillin; Phosphorylation; Protein phosphatase 2a; Src

Indexed keywords

FOCAL ADHESION KINASE; PAXILLIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BIRDS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DOWN-REGULATION; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GENES, SRC; HUMANS; MICE; MUTATION; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PAXILLIN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PHOSPHOTYROSINE; PRECIPITIN TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES;

EID: 0037211492     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10772     Document Type: Article

References (38)

1. Bernstein LR, Liotta LA. Molecular mediators of interactions with extracellular matrix components in metastasis,and angiogenesis. Current Opinion Oncol 1994;6:106-13.
2. Wells A. Tumor invasion: Role of growth factor-induced cell motility. Adv Cancer Res 2000;78:31-101.
3. Young MRI, Liu SW, Meisinger J. Differences in association of the serine/threonine protein phosphatase PP-2A/with microtubules of metastatic and nonmetastatic tumor cells. Clin Exp Met 2001;18:40713.
4. Otto T, Lummen G, Be A, Rubben H, Raz A. Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinical results. Adv Exp Med Biol 1999;462:469-76.
5. Nakayama S, Sasaki A, Mese H, Alcalde RE, Matsumura T. Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma. Invasion Metastasis 1998;18:219-28.
6. Cary LA, Guan JL. Focal adhesion kinase in integrin-mediated signaling. Front Biosci 1999;4:D102-13.
7. Jones RJ, Brunton VG, Frame MC. Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. Eur J Cancer 2000;36:1595-606.
8. Greenwood JA, Theibert AB, Prestwich GD, Murphy-Ullrich JE. Restructuring of focal adhesion plaques by PI 3-kinase. Regulation by PtdIns (3,4,5)-p(3) binding to α-actinin. J Cell Biol 2000;150:627-42.
9. Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 1998;20:745-52.
10. Beviglia L, Kramer RH. HGF induces FAK activation and integrinmediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer 1999;83:640-9.
11. Yu CF, Sanders MA, Basson MD. Human caco-2 motility redistributes FAK and paxillin and activates p38 MAPK in a matrix-dependent manner. Am J Physiol Gastrointest Liver Physiol 2000;278:G952-66.
12. Maher PA. Disruption of cell-substrate adhesion activates the protein tyrosine kinase pp60 (c-src). Exp Cell Res 2000;260:189-98.
13. Kintscher U, Wakino S, Kim S, Fleck E, Hsueh WA, Law RE. Angiotensin II induces migration and Pyk2/Paxillin phosphorylation of human monocytes. Hypertension 2001;37:587-93.
14. Yamada T, Aoyama Y, Owada MK, Kawakatsu H, Kitajima Y. Scraped-wounding causes activation and association of C-Src tyrosine kinase with microtubules in cultured keratinocytes. Cell Struct Funct 2000;25:351-9.
15. 3 integrinmediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001;152:181-95.
16. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, Cance WG. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996;3:100-5.
17. Turner CE. Paxillin and focal adhesion signaling. Nat Cell Biol 2000;2:E231-6.
18. Bellis SL, Perrotta JA, Curtis MS, Turner CE. Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem J 1997;325:375-81.
19. Bellis SL, Miller JT, Turner CE. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 1995;270:17437-41.
20. Guvakova MA, Surmacz E. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin. Exp Cell Res 1999;251:244-55.
21. Han JD, Rubin CS. Regulation of cytoskeleton organization and paxillin dephosphorylation by cAMP. Studies on murine Y1 adrenal cells. J Biol Chem 1996;271:29211-5.
22. Romer LH, Burridge K, Turner CE. Signaling between the extracellular matrix and the cytoskeleton: Tyrosine phosphorylation and focal adhesion assembly. Cold Spring Harb Symp Quant Biol 1992;57:193-202.
23. Vadlamudi R, Adam L, Talukder A, Mendelsohn J, Kumar R. Serine phosphorylation of paxillin by heregulin-β1: Role of p38 mitogen activated protein kinase. Oncogene 1999;18:7253-64.
24. Young MR. Protein phosphatases-1 and -2A regulate tumor cell migration, invasion and cytoskeletal organization. Adv Exp Med Biol 1997;407:311-8.
25. 2-producing nonmetastatic Lewis lung carcinoma variants. Cancer Res 1990;50:2973-8.
26. Brown MC, Perrotta JA, Turner CE. Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol Biol Cell 1998;9:1803-16.
27. 3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A. Invasion Metastasis 1997;16:280-90.
28. Wadzinski BE, Eisfelder BJ, Peruski LF Jr, Mumby MC, Johnson GL. NH2-terminal modification of the phosphatase 2A catalytic subunit allows functional expression in mammalian cells. J Biol Chem 1992;267:16883-8.
29. Favre B, Zolnierowicz S, Turowski P, Hemmings BA. The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 1994;269:16311-7.
30. Hardie DG, Haystead AJ, Sim ATR. Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol 1991;201:469-76.
31. Cohen, P. The structure and regulation of protein phosphatases. In: Nishizuka Y. ed. The Biology and Medicine of Signal Transduction. New York, Raven Press, 1990. 230-5.
32. Cohen P. Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol 1991;201:389-427.
33. Meisinger J, Patel S, Vellody K, Bergstrom R, Benefield J, Lozano Y, Young MRI. Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells. Cancer Lett 1997;111:87-95.
34. Gabel S, Benefield J, Meisinger J, Petruzzelli G, Young MRI. Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngol Head and Neck Surg 1999;121:463-8.
35. Benefield J, Meisinger J, Petruzzelli GJ, Young MRI. Endothelial cell response to human head and neck squamous cell carcinoma cells involves downregulation of protein phosphatases-1/2A, cytoskeletal depolymerization and increased motility. Invasion Metastasis 1997;17:210-20.
36. Kawada M, Amemiya M, Ishizuka M, Takeuchi T. Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A. Biochim Biophys Acta 1999;1452:209-17.
37. Chackalaparampil I, Bagrodia S, Shalloway D. Tyrosine dephosphorylation of pp60c-src is stimulated by a serine/threonine phosphatase inhibitor. Oncogene 1994;9:1947-55.
38. CAS. Oncogene 2001;20:6057-65.